According to France 24, a new HIV preventive treatment called Lenacapavir is rolling out across Southern Africa. Administered just twice a year, the drug has demonstrated more than 99 percent effectiveness in clinical trials. The campaign targets six nations—South Africa, Zambia, Eswatini, Zimbabwe, Lesotho, and Mozambique—the region most affected by the HIV and AIDS epidemic.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton